# Celea Therapeutics funding rounds and investors

As of 14 Oct 2026, Celea Therapeutics has raised $180M across 1 verified round on record; latest: $180 million funding round, announced 2 Jul 2026.

Celeatx offers investigational medications, particularly deupirfenidone, for the treatment of idiopathic pulmonary fibrosis (IPF).

Website: https://celeatx.com  
Page: https://fireround.dev/companies/celeatx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-07-02 | Funding round | $180 million | not stated | Leaps by Bayer, PureTech, RA Capital Management | [biopharmadive.com](https://www.biopharmadive.com/news/celea-puretech-idiopathic-pulmonary-fibrosis-raise/824330) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.